4-Bromo-1-(6-methoxypyridin-3-yl)-1H-indazole

Catalog No. :
ACVQBN567
CAS No. :
1207478-79-2
Molecular Formula :
C13H10BrN3O
Molecular Weight :
304.15

IUPAC Name:4-bromo-1-(6-methoxypyridin-3-yl)-1H-indazole

4-Bromo-1-(6-methoxypyridin-3-yl)-1H-indazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$55.00Login to see priceIn stockInquiry
500mg95%$80.00Login to see priceIn stockInquiry
1g95%$118.00Login to see priceIn stockInquiry
5g95%$355.00Login to see priceIn stockInquiry
10g95%$594.00Login to see priceIn stockInquiry
25g95%$1186.00Login to see priceIn stockInquiry
50g95%$1896.00Login to see priceIn stockInquiry
100g95%$3093.00Login to see priceInquiryInquiry
250g95%$6185.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-1-(6-methoxypyridin-3-yl)-1H-indazole
IUPAC Name4-bromo-1-(6-methoxypyridin-3-yl)-1H-indazole
Molecular FormulaC13H10BrN3O
Molecular Weight304.15
SMILESCOC1=CC=C(N2N=CC3=C2C=CC=C3Br)C=N1
InChI KeyYKEZYQVLCSIEHQ-UHFFFAOYSA-N
Synonym1H-Indazole, 4-bromo-1-(6-methoxy-3-pyridinyl)-;4-Bromo-1-(6-methoxy-3-pyridinyl)-1H-indazole;4-bromo-1-(6-methoxy-3-pyridyl)indazole
CAS No.1207478-79-2

Synthetic Route by SureRoute

1. ACVQBN567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRDBJ791 route compound structure diagram
    ACRDBJ79113472-85-0 In Stock
  4. Then
  5. ACVQBN567 route product structure diagram
    ACVQBN5671207478-79-2 In Stock
Inquiry

2. ACVQBN567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLXFV976 route compound structure diagram
    ACLXFV97613472-61-2 In Stock
  4. Then
  5. ACVQBN567 route product structure diagram
    ACVQBN5671207478-79-2 In Stock
Inquiry

Comments (0)